Mitochondrial Metabolism in Breast Cancer
Frontiers in Bioscience-Landmark · 2026-03-16 · 31 (3)
DOI: 10.31083/fbl45543 ↗At a glance
Übersichtsarbeit in Frontiers in Bioscience-Landmark, published online on 2026-03-16. Written by Qian Hu and 11 co-authors. Institution: Pharmacy and Pharmacology, University of South China, 421001 Hengyang, Hunan, China. Major MEDLINE topics: Mitochondria, Breast Neoplasms. Cited 1 times so far (Crossref); 124 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China (NSFC)-General Program, Shenzhen Science and Technology Innovation Commission-Basic Research (General Program), National Natural Science Foundation of China (NSFC)—General Program.
Abstract (original language)
Breast cancer is the most prevalent malignant tumor among women worldwide. Its progression is driven, in part, by mitochondrial metabolic dysregulation, which can also contribute to therapeutic resistance. Although targeting mitochondrial metabolism offers new opportunities for treatment, significant therapeutic challenges remain. These include metabolic heterogeneity among subtypes and individual patients, drug resistance arising from metabolic plasticity, and suboptimal clinical translation of metabolic therapies. This review systematically synthesizes the mitochondrial metabolic mechanisms underlying different breast cancer subtypes, emphasizing the spatial network regulatory functions of mitochondrial metabolism. It further critically evaluates combined therapeutic strategies targeting metabolic vulnerabilities. By integrating current research limitations with emerging breakthroughs, we outline novel therapeutic frameworks to advance the development of precision medicine approaches focused on mitochondrial metabolism.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Pharmacy and Pharmacology, University of South China, 421001 Hengyang, Hunan, China.
- Laboratory Medicine Center, Shenzhen Luohu Hospital Group, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen University, 518001 Shenzhen, Guangdong, China.
- School of Medicine, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China.
- Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, The F…
Funding
- National Natural Science Foundation of China (NSFC)-General Program
- Shenzhen Science and Technology Innovation Commission-Basic Research (General Program)
- National Natural Science Foundation of China (NSFC)—General Program
- Shenzhen Science and Technology Innovation Commission—Basic Research
Cite
APA
Hu, Q., Luo, Z., Yuan, W., Zou, Q., Wang, L., He, Y., Shen, Y., Wen, X., Chen, S., Liu, Q., Luo, D., & Guo, Z. (2026). Mitochondrial Metabolism in Breast Cancer. Frontiers in Bioscience-Landmark, 31(3). https://doi.org/10.31083/fbl45543
Vancouver
Hu Q, Luo Z, Yuan W, Zou Q, Wang L, He Y, et al. Mitochondrial Metabolism in Breast Cancer. Frontiers in Bioscience-Landmark. 2026;31(3). doi:10.31083/fbl45543
BibTeX
@article{Hu2026,
author = {Hu, Qian and Luo, Zhihao and Yuan, Weixi and Zou, Qingshuang and Wang, Li and He, Yan and Shen, Yao and Wen, Xiaosha and Chen, Shang and Liu, Quan and Luo, Dixian and Guo, Zifen},
title = {Mitochondrial Metabolism in Breast Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {3},
doi = {10.31083/fbl45543}
}
EUVIMED